Regeneron (REGN) Tops Q1 EPS by 47c
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $620.21 +1.26%
EPS Growth %: -15.8%
Financial Fact:
Other collaboration revenue: 191.3M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -15.8%
Financial Fact:
Other collaboration revenue: 191.3M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q1 EPS of $6.60, $0.47 better than the analyst estimate of $6.13. Revenue for the quarter came in at $1.83 billion versus the consensus estimate of $1.76 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
- Carnival shares drop despite earnings beat on weak guidance
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
